Data / Form D filings / Dvant Pharma, Inc.
Dvant Pharma, Inc.: Form D filing
Dvant Pharma, Inc., a biotechnology company in Superior Township, MI, filed a Form D with the SEC in 2026. The latest, on October 13, 2026, reports $1.2 million sold of a $3.1 million offering to 9 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 3646 NORTHBROOK DRIVE, Superior Township, MI, 48198
- Phone
- (734) 249-9234
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2158986
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Oct 13 | New notice | $3,090,400 | $1,230,400 | $1,860,000 | 9 | Sep 29 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Andrew Joseph Kocab | Executive Officer, Director | |
| Mukesh Nyati | Executive Officer, Director | |
| Vincent Alessi | Director | |
| Jim Adox | Director | |
| Frank Perabo | Director |
Every Form D from the week of Oct 12 · All recent filings in Michigan · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Dvant Pharma, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.